ClinicaliQ Trial Snapshot
- Met Non Small Cell Cancer Registry (MOMENT) — Recruiting • Oncology • NCT05376891.
- What is being tested: MOMENT is a prospective multi-national disease registry collecting standardized longitudinal data on non-small cell lung cancer (NSCLC) treatment patterns and clinical outcomes to track real-world changes in the evolving treatment landscape.
- Patient eligibility overview: The registry enrolls patients with confirmed NSCLC diagnoses across multiple countries, capturing diverse patient populations and treatment pathways through systematic prospective follow-up.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14(METex14) participants treated with systemic therapy.
Eligibility Snapshot
- : * Participants who signed ICF * Participants with advanced stage (stages IIIB-IV) NSCLC (all histologies) and Confirmed METex14 skipping alterations (by valid assay) * Participants who are starting or are already being treated with systemic therapy
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.